Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Springfield, IL
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Springfield, IL
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Indianapolis, IN
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Louisville, KY
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Baltimore, MD
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Saint Louis, MO
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Omaha, NE
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
North Plainfield, NJ
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
North Plainfield, NJ
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Flushing, NY
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Flushing, NY
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Lake Success, NY
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Lake Success, NY
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
New Hyde Park, NY
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Staten Island, NY
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Staten Island, NY
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Morehead City, NC
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Morehead City, NC
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Raleigh, NC
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Medford, OR
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Medford, OR
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Downingtown, PA
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Downingtown, PA
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Sellersville, PA
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Sellersville, PA
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Sioux Falls, SD
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Dallas, TX
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Houston, TX
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
San Antonio, TX
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Renton, WA
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Renton, WA
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Milwaukee, WI
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Investigational Site Number 056010
mi
from
Aalst,
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Investigational Site Number 056010
mi
from
Aalst,
Click here to add this to my saved trials
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Aurora, CO
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Miami, FL
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Atlanta, GA
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Idaho Falls, ID
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Springfield, IL
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Springfield, IL
Click here to add this to my saved trials
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Indianapolis, IN
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Baltimore, MD
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Grand Rapids, MI
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
New York, NY
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Philadelphia, PA
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Dallas, TX
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
El Paso, TX
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
El Paso, TX
Click here to add this to my saved trials
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
San Antonio, TX
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Ogden, UT
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Ogden, UT
Click here to add this to my saved trials
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
mi
from
Buenos Aires,
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
mi
from
Buenos Aires,
Click here to add this to my saved trials
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Santa Ana, CA
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Washington,
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Hollywood, FL
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Hollywood, FL
Click here to add this to my saved trials
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
New Port Richey, FL
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
New Port Richey, FL
Click here to add this to my saved trials
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
South Miami, FL
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
South Miami, FL
Click here to add this to my saved trials
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Honolulu, HI
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Honolulu, HI
Click here to add this to my saved trials
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Idaho Falls, ID
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
New Orleans, LA
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
New Orleans, LA
Click here to add this to my saved trials
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Biddeford, ME
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Biddeford, ME
Click here to add this to my saved trials
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Minneapolis, MN
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Stratford, NJ
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Stratford, NJ
Click here to add this to my saved trials
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Greenville, SC
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Greenville, SC
Click here to add this to my saved trials